757 Spam-Free Article(s) Found
Sep 02, 2015 - ARIAD's (ARIA) shares shot up on acquisition rumors; Amgen (AMGN) gained FDA approval for its potential blockbuster treatment, Repatha.
Aug 31, 2015 - Alnylam (ALNY) and The Medicines Company (MDCO) presented initial data from their ongoing phase I study on ALN-PCSsc for the treatment of hypercholesterolemia.
Aug 28, 2015 - Will FDA approval of Amgen's (AMGN) Repatha trigger a pricing war for this class of treatment?
Aug 27, 2015 - The Zacks Analyst Blog Highlights: Vital Therapies, Amgen, BioMarin, Acorda and Macrocure
Aug 26, 2015 - It was a mixed week for the biotech sector with companies like Acorda (ACOR) and BioMarin (BMRN) providing positive updates while others saw their share prices crashing on disappointing data.
Aug 12, 2015 - Bull of the Day: Regeneron Pharma (REGN)
Jul 24, 2015 - Earnings Growth Hard to Come By